tiprankstipranks
Integra LifeSciences price target raised to $22 from $16 at Citi
The Fly

Integra LifeSciences price target raised to $22 from $16 at Citi

Citi raised the firm’s price target on Integra LifeSciences (IART) to $22 from $16 and keeps a Sell rating on the shares. The company reported a somewhat better than expected Q3, the analyst tells investors in a research note. The firm says likely the most important part of the Q3 call was the appointment of Mojdeh Poul as new CEO effective January, “bringing fresh eyes to the organization.”

Pick the best stocks and maximize your portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App